Followers | 127 |
Posts | 5373 |
Boards Moderated | 0 |
Alias Born | 06/09/2020 |
Friday, November 18, 2022 10:39:33 AM
News is spreading around the world. Picked up news in England, Japan, China, India, the US and I have contacted all danish news medias and television.
This is a medley of greatest hits and I am counting on it will get much much higher the coming days, weeks and months, when this is going to be common knowledge.
Lovely to see Peter Doherty, the Nobel Prize laureate chime in with an endorsement of approval. The british cancer organisations are also out in favor of DCVax-L just as we knew they would, since Hugh Adams from Brain Tumour Research has been the facilitator of getting the NWBO management to meet british politicians.
What kind of news have NWBO accumulated for us? What is next in line?
We know they had around 100 days since August knowing about this publication, so they definitely are going to try to live up to their
"roll out one package of events".
I think we should let shorts find out for themselves.
They have decided to place themselves on the wrong side of history and actively work against not only a working treatment for the worst kind of cancer in the world, but probably very close to a cure, when combining DCVax-L with checkpoint inhibitors and Poly-ICLC.
I can only say, that I am going to enjoy every second of it.
Enjoy your weekend fellow longs.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM